{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,27]],"date-time":"2026-09-27T03:47:36Z","timestamp":1790480856574,"version":"4.1.0"},"reference-count":45,"publisher":"Springer Science and Business Media LLC","issue":"1","content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Exp Clin Cancer Res"],"published-print":{"date-parts":[[2010,12]]},"abstract":"<jats:title>Abstract<\/jats:title>\n          <jats:p>Patients with cervical carcinoma (CC) are frequently immunocompromised. Dendritic cells (DCs) are potent antigen-presenting cells. Using multicolor flow cytometry, the percentages of CD11c+ (DC1) and CD123+ (DC2) subsets, were determined in the peripheral blood of 37 patients with cervical carcinoma (CC), 54 patients with CIN, and 62 healthy individuals. A substantial reduction of circulating dendritic cells and accordingly immunodepression may be associated with increased IL-6 and TGF-\u03b2 in serum. These findings could give expression to the immunosuppression of circulating dendritic cells in patients with CC and CIN, thus, may indicate novel aspects of cervical carcinoma immune evasion.<\/jats:p>","DOI":"10.1186\/1756-9966-29-78","type":"journal-article","created":{"date-parts":[[2010,6,18]],"date-time":"2010-06-18T18:14:36Z","timestamp":1276884876000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":15,"title":["Alterations of dendritic cell subsets in the peripheral circulation of patients with cervical carcinoma"],"prefix":"10.1186","volume":"29","author":[{"given":"Feng","family":"Ye","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yan","family":"Yu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuting","family":"Hu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Weiguo","family":"Lu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xing","family":"Xie","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2010,6,18]]},"reference":[{"key":"325_CR1","doi-asserted-by":"publisher","first-page":"18","DOI":"10.1002\/(SICI)1097-0215(19990924)83:1<18::AID-IJC5>3.0.CO;2-M","volume":"83","author":"P Pisani","year":"1999","unstructured":"Pisani P, Parkin DM, Bray F, Ferlay J: Estimates of the worldwide mortality from 25 cancers in 1990. International journal of cancer. 1999, 83: 18-29. 10.1002\/(SICI)1097-0215(19990924)83:1<18::AID-IJC5>3.0.CO;2-M.","journal-title":"International journal of cancer"},{"issue":"356","key":"325_CR2","first-page":"e1","volume":"197","author":"PE Castle","year":"2007","unstructured":"Castle PE, Sideri M, Jeronimo J, Solomon D, Schiffman M: Risk assessment to guide the prevention of cervical cancer. American journal of obstetrics and gynecology. 2007, 197 (356): e1-6.","journal-title":"American journal of obstetrics and gynecology"},{"key":"325_CR3","first-page":"65","volume":"244","author":"FX Bosch","year":"2002","unstructured":"Bosch FX, Lorincz A, Munoz N, Meijer CJ, Shah KV: The causal relation between human papillomavirus and cervical cancer. Journal of clinical pathology. 2002, 244: 65-","journal-title":"Journal of clinical pathology"},{"issue":"435","key":"325_CR4","first-page":"40","volume":"181","author":"LA Pekarek","year":"1995","unstructured":"Pekarek LA, Starr BA, Toledano AY, Schreiber H: Inhibition of tumor growth by elimination of granulocytes. The Journal of experimental medicine. 1995, 181 (435): 40-","journal-title":"The Journal of experimental medicine"},{"key":"325_CR5","doi-asserted-by":"publisher","first-page":"254","DOI":"10.1016\/S1071-5576(02)00166-1","volume":"9","author":"MA Steller","year":"2002","unstructured":"Steller MA: Cervical cancer vaccines: progress and prospects. Journal of the Society for Gynecologic Investigation. 2002, 9: 254-64. 10.1016\/S1071-5576(02)00166-1.","journal-title":"Journal of the Society for Gynecologic Investigation"},{"key":"325_CR6","first-page":"3406","volume":"6","author":"L Muderspach","year":"2000","unstructured":"Muderspach L, Wilczynski S, Roman L, et al: A phase I trial of a human papillomavirus (HPV) peptide vaccine for women with high-grade cervical and vulvar intraepithelial neoplasia who are HPV 16 positive. Clin Cancer Res. 2000, 6: 3406-16.","journal-title":"Clin Cancer Res"},{"key":"325_CR7","doi-asserted-by":"publisher","first-page":"535","DOI":"10.1016\/S0140-6736(97)02250-2","volume":"350","author":"F Landoni","year":"1997","unstructured":"Landoni F, Maneo A, Colombo A, et al: Randomised study of radical surgery versus radiotherapy for stage Ib-IIa cervical cancer. Lancet. 1997, 350: 535-40. 10.1016\/S0140-6736(97)02250-2.","journal-title":"Lancet"},{"key":"325_CR8","doi-asserted-by":"publisher","first-page":"2966","DOI":"10.1200\/JCO.2006.09.3781","volume":"25","author":"HJ Long","year":"2007","unstructured":"Long HJ: Management of metastatic cervical cancer: review of the literature. J Clin Oncol. 2007, 25: 2966-74. 10.1200\/JCO.2006.09.3781.","journal-title":"J Clin Oncol"},{"key":"325_CR9","doi-asserted-by":"publisher","first-page":"117","DOI":"10.1016\/0046-8177(92)90232-R","volume":"23","author":"MH Stoler","year":"1992","unstructured":"Stoler MH, Rhodes CR, Whitbeck A, Wolinsky SM, Chow LT, Broker TR: Human papillomavirus type 16 and 18 gene expression in cervical neoplasias. Human pathology. 1992, 23: 117-28. 10.1016\/0046-8177(92)90232-R.","journal-title":"Human pathology"},{"key":"325_CR10","doi-asserted-by":"publisher","first-page":"650","DOI":"10.1002\/ijc.2910570507","volume":"57","author":"S Honma","year":"1994","unstructured":"Honma S, Tsukada S, Honda S, et al: Biological-clinical significance of selective loss of HLA-class-I allelic product expression in squamous-cell carcinoma of the uterine cervix. International journal of cancer. 1994, 57: 650-5. 10.1002\/ijc.2910570507.","journal-title":"International journal of cancer"},{"key":"325_CR11","doi-asserted-by":"publisher","first-page":"464","DOI":"10.1016\/0167-5699(94)90190-2","volume":"15","author":"BJ Nickoloff","year":"1994","unstructured":"Nickoloff BJ, Turka LA: Immunological functions of non-professional antigen-presenting cells: new insights from studies of T-cell interactions with keratinocytes. Immunology today. 1994, 15: 464-9. 10.1016\/0167-5699(94)90190-2.","journal-title":"Immunology today"},{"key":"325_CR12","doi-asserted-by":"publisher","first-page":"271","DOI":"10.1146\/annurev.iy.09.040191.001415","volume":"9","author":"RM Steinman","year":"1991","unstructured":"Steinman RM: The dendritic cell system and its role in immunogenicity. Annual review of immunology. 1991, 9: 271-96. 10.1146\/annurev.iy.09.040191.001415.","journal-title":"Annual review of immunology"},{"key":"325_CR13","doi-asserted-by":"publisher","first-page":"787","DOI":"10.1016\/S0264-410X(02)00599-6","volume":"21","author":"M Adams","year":"2003","unstructured":"Adams M, Navabi H, Jasani B, et al: Dendritic cell (DC) based therapy for cervical cancer: use of DC pulsed with tumour lysate and matured with a novel synthetic clinically non-toxic double stranded RNA analogue poly [I]:poly [C(12)U] (Ampligen R). Vaccine. 2003, 21: 787-90. 10.1016\/S0264-410X(02)00599-6.","journal-title":"Vaccine"},{"key":"325_CR14","doi-asserted-by":"publisher","first-page":"3485","DOI":"10.2174\/138161205774414565","volume":"11","author":"AD Santin","year":"2005","unstructured":"Santin AD, Bellone S, Roman JJ, Burnett A, Cannon MJ, Pecorelli S: Therapeutic vaccines for cervical cancer: dendritic cell-based immunotherapy. Current pharmaceutical design. 2005, 11: 3485-500. 10.2174\/138161205774414565.","journal-title":"Current pharmaceutical design"},{"key":"325_CR15","doi-asserted-by":"publisher","first-page":"948","DOI":"10.1038\/sj.cgt.7700391","volume":"8","author":"Y Liu","year":"2001","unstructured":"Liu Y, Chiriva-Internati M, Grizzi F, et al: Rapid induction of cytotoxic T-cell response against cervical cancer cells by human papillomavirus type 16 E6 antigen gene delivery into human dendritic cells by an adeno-associated virus vector. Cancer gene therapy. 2001, 8: 948-57. 10.1038\/sj.cgt.7700391.","journal-title":"Cancer gene therapy"},{"key":"325_CR16","doi-asserted-by":"publisher","first-page":"469","DOI":"10.1016\/j.ygyno.2005.09.040","volume":"100","author":"AD Santin","year":"2006","unstructured":"Santin AD, Bellone S, Palmieri M, et al: HPV16\/18 E7-pulsed dendritic cell vaccination in cervical cancer patients with recurrent disease refractory to standard treatment modalities. Gynecologic oncology. 2006, 100: 469-78. 10.1016\/j.ygyno.2005.09.040.","journal-title":"Gynecologic oncology"},{"key":"325_CR17","doi-asserted-by":"publisher","first-page":"521","DOI":"10.1007\/s00432-003-0463-5","volume":"129","author":"A Ferrara","year":"2003","unstructured":"Ferrara A, Nonn M, Sehr P, et al: Dendritic cell-based tumor vaccine for cervical cancer II: results of a clinical pilot study in 15 individual patients. Journal of cancer research and clinical oncology. 2003, 129: 521-30. 10.1007\/s00432-003-0463-5.","journal-title":"Journal of cancer research and clinical oncology"},{"key":"325_CR18","doi-asserted-by":"publisher","first-page":"551","DOI":"10.1007\/s10875-005-8216-7","volume":"25","author":"P Dubsky","year":"2005","unstructured":"Dubsky P, Ueno H, Piqueras B, Connolly J, Banchereau J, Palucka AK: Human dendritic cell subsets for vaccination. Journal of clinical immunology. 2005, 25: 551-72. 10.1007\/s10875-005-8216-7.","journal-title":"Journal of clinical immunology"},{"key":"325_CR19","doi-asserted-by":"publisher","first-page":"2558","DOI":"10.1016\/j.molimm.2006.12.020","volume":"44","author":"M Chen","year":"2007","unstructured":"Chen M, Huang L, Shabier Z, Wang J: Regulation of the lifespan in dendritic cell subsets. Molecular immunology. 2007, 44: 2558-65. 10.1016\/j.molimm.2006.12.020.","journal-title":"Molecular immunology"},{"key":"325_CR20","doi-asserted-by":"publisher","first-page":"107","DOI":"10.1126\/science.1136080","volume":"315","author":"D Dudziak","year":"2007","unstructured":"Dudziak D, Kamphorst AO, Heidkamp GF, et al: Differential antigen processing by dendritic cell subsets in vivo. Science (New York, NY). 2007, 315: 107-11.","journal-title":"Science (New York, NY)"},{"key":"325_CR21","doi-asserted-by":"publisher","first-page":"1219","DOI":"10.1038\/ni1141","volume":"5","author":"M Colonna","year":"2004","unstructured":"Colonna M, Trinchieri G, Liu YJ: Plasmacytoid dendritic cells in immunity. Nature immunology. 2004, 5: 1219-26. 10.1038\/ni1141.","journal-title":"Nature immunology"},{"key":"325_CR22","doi-asserted-by":"publisher","first-page":"863","DOI":"10.1084\/jem.194.6.863","volume":"194","author":"N Kadowaki","year":"2001","unstructured":"Kadowaki N, Ho S, Antonenko S, et al: Subsets of human dendritic cell precursors express different toll-like receptors and respond to different microbial antigens. The Journal of experimental medicine. 2001, 194: 863-9. 10.1084\/jem.194.6.863.","journal-title":"The Journal of experimental medicine"},{"key":"325_CR23","first-page":"45","volume":"42","author":"K Wojas","year":"2004","unstructured":"Wojas K, Tabarkiewicz J, Jankiewicz M, Rolinski J: Dendritic cells in peripheral blood of patients with breast and lung cancer--a pilot study. Folia histochemica et cytobiologica\/Polish Academy of Sciences, Polish Histochemical and Cytochemical Society. 2004, 42: 45-8.","journal-title":"Folia histochemica et cytobiologica\/Polish Academy of Sciences, Polish Histochemical and Cytochemical Society"},{"key":"325_CR24","first-page":"113","volume":"14","author":"S Ferrari","year":"2005","unstructured":"Ferrari S, Malugani F, Rovati B, Porta C, Riccardi A, Danova M: Flow cytometric analysis of circulating dendritic cell subsets and intracellular cytokine production in advanced breast cancer patients. Oncology reports. 2005, 14: 113-20.","journal-title":"Oncology reports"},{"key":"325_CR25","doi-asserted-by":"publisher","first-page":"645","DOI":"10.1038\/sj.leu.2404146","volume":"20","author":"B Maecker","year":"2006","unstructured":"Maecker B, Mougiakakos D, Zimmermann M, et al: Dendritic cell deficiencies in pediatric acute lymphoblastic leukemia patients. Leukemia. 2006, 20: 645-9. 10.1038\/sj.leu.2404146.","journal-title":"Leukemia"},{"key":"325_CR26","doi-asserted-by":"publisher","first-page":"991","DOI":"10.1016\/S0360-3016(00)00729-X","volume":"48","author":"J Dickson","year":"2000","unstructured":"Dickson J, Davidson SE, Hunter RD, West CM: Pretreatment plasma TGF beta 1 levels are prognostic for survival but not morbidity following radiation therapy of carcinoma of the cervix. International journal of radiation oncology, biology, physics. 2000, 48: 991-5. 10.1016\/S0360-3016(00)00729-X.","journal-title":"International journal of radiation oncology, biology, physics"},{"key":"325_CR27","doi-asserted-by":"publisher","first-page":"230","DOI":"10.1182\/blood.V100.1.230","volume":"100","author":"M Ratta","year":"2002","unstructured":"Ratta M, Fagnoni F, Curti A, et al: Dendritic cells are functionally defective in multiple myeloma the role of interleukin-6. Blood. 2002, 100: 230-7. 10.1182\/blood.V100.1.230.","journal-title":"Blood"},{"key":"325_CR28","doi-asserted-by":"publisher","first-page":"303","DOI":"10.1016\/S0169-409X(00)00048-X","volume":"41","author":"SV Walsh","year":"2000","unstructured":"Walsh SV, Hopkins AM, Nusrat A: Modulation of tight junction structure and function by cytokines. Advanced drug delivery reviews. 2000, 41: 303-13. 10.1016\/S0169-409X(00)00048-X.","journal-title":"Advanced drug delivery reviews"},{"key":"325_CR29","doi-asserted-by":"publisher","first-page":"7260","DOI":"10.1158\/1078-0432.CCR-04-0872","volume":"10","author":"S Beckebaum","year":"2004","unstructured":"Beckebaum S, Zhang X, Chen X, et al: Increased levels of interleukin-10 in serum from patients with hepatocellular carcinoma correlate with profound numerical deficiencies and immature phenotype of circulating dendritic cell subsets. Clin Cancer Res. 2004, 10: 7260-9. 10.1158\/1078-0432.CCR-04-0872.","journal-title":"Clin Cancer Res"},{"key":"325_CR30","first-page":"1351","volume":"6","author":"T Saito","year":"2000","unstructured":"Saito T, Dworacki G, Gooding W, Lotze MT, Whiteside TL: Spontaneous apoptosis of CD8+ T lymphocytes in peripheral blood of patients with advanced melanoma. Clin Cancer Res. 2000, 6: 1351-64.","journal-title":"Clin Cancer Res"},{"key":"325_CR31","doi-asserted-by":"publisher","first-page":"942","DOI":"10.1038\/nm1093","volume":"10","author":"TJ Curiel","year":"2004","unstructured":"Curiel TJ, Coukos G, Zou L, et al: Specific recruitment of regulatory T cells in ovarian carcinoma fosters immune privilege and predicts reduced survival. Nature medicine. 2004, 10: 942-9. 10.1038\/nm1093.","journal-title":"Nature medicine"},{"key":"325_CR32","doi-asserted-by":"publisher","first-page":"4333","DOI":"10.4049\/jimmunol.168.9.4333","volume":"168","author":"CC Sombroek","year":"2002","unstructured":"Sombroek CC, Stam AG, Masterson AJ, et al: Prostanoids play a major role in the primary tumor-induced inhibition of dendritic cell differentiation. J Immunol. 2002, 168: 4333-43.","journal-title":"J Immunol"},{"key":"325_CR33","doi-asserted-by":"publisher","first-page":"1463","DOI":"10.1038\/sj.bjc.6601243","volume":"89","author":"S Della Bella","year":"2003","unstructured":"Della Bella S, Gennaro M, Vaccari M, et al: Altered maturation of peripheral blood dendritic cells in patients with breast cancer. British journal of cancer. 2003, 89: 1463-72. 10.1038\/sj.bjc.6601243.","journal-title":"British journal of cancer"},{"key":"325_CR34","first-page":"216","volume":"13","author":"P Lissoni","year":"1999","unstructured":"Lissoni P, Vigore L, Ferranti R, et al: Circulating dendritic cells in early and advanced cancer patients: diminished percent in the metastatic disease. Journal of biological regulators and homeostatic agents. 1999, 13: 216-9.","journal-title":"Journal of biological regulators and homeostatic agents"},{"key":"325_CR35","doi-asserted-by":"publisher","first-page":"270","DOI":"10.1046\/j.1365-2249.2003.02295.x","volume":"134","author":"A Huang","year":"2003","unstructured":"Huang A, Gilmour JW, Imami N, Amjadi P, Henderson DC, Allen-Mersh TG: Increased serum transforming growth factor-beta1 in human colorectal cancer correlates with reduced circulating dendritic cells and increased colonic Langerhans cell infiltration. Clinical and experimental immunology. 2003, 134: 270-8. 10.1046\/j.1365-2249.2003.02295.x.","journal-title":"Clinical and experimental immunology"},{"key":"325_CR36","first-page":"1787","volume":"8","author":"TK Hoffmann","year":"2002","unstructured":"Hoffmann TK, Muller-Berghaus J, Ferris RL, Johnson JT, Storkus WJ, Whiteside TL: Alterations in the frequency of dendritic cell subsets in the peripheral circulation of patients with squamous cell carcinomas of the head and neck. Clin Cancer Res. 2002, 8: 1787-93.","journal-title":"Clin Cancer Res"},{"key":"325_CR37","doi-asserted-by":"publisher","first-page":"190","DOI":"10.1111\/j.1610-0387.2007.06179.x","volume":"5","author":"A Tuettenberg","year":"2007","unstructured":"Tuettenberg A, Schmitt E, Knop J, Jonuleit H: Dendritic cell-based immunotherapy of malignant melanoma: success and limitations. J Dtsch Dermatol Ges. 2007, 5: 190-6. 10.1111\/j.1610-0387.2007.06179.x.","journal-title":"J Dtsch Dermatol Ges"},{"key":"325_CR38","doi-asserted-by":"publisher","first-page":"2756","DOI":"10.4049\/jimmunol.169.5.2756","volume":"169","author":"UK Liyanage","year":"2002","unstructured":"Liyanage UK, Moore TT, Joo HG, et al: Prevalence of regulatory T cells is increased in peripheral blood and tumor microenvironment of patients with pancreas or breast adenocarcinoma. J Immunol. 2002, 169: 2756-61.","journal-title":"J Immunol"},{"key":"325_CR39","doi-asserted-by":"publisher","first-page":"999","DOI":"10.1002\/cncr.22092","volume":"107","author":"BN Lee","year":"2006","unstructured":"Lee BN, Follen M, Rodriquez G, et al: Deficiencies in myeloid antigen-presenting cells in women with cervical squamous intraepithelial lesions. Cancer. 2006, 107: 999-1007. 10.1002\/cncr.22092.","journal-title":"Cancer"},{"key":"325_CR40","doi-asserted-by":"publisher","first-page":"253","DOI":"10.1016\/j.smim.2005.05.008","volume":"17","author":"W Barchet","year":"2005","unstructured":"Barchet W, Cella M, Colonna M: Plasmacytoid dendritic cells--virus experts of innate immunity. Seminars in immunology. 2005, 17: 253-61. 10.1016\/j.smim.2005.05.008.","journal-title":"Seminars in immunology"},{"key":"325_CR41","doi-asserted-by":"publisher","first-page":"276","DOI":"10.1159\/000086784","volume":"68","author":"M Della Porta","year":"2005","unstructured":"Della Porta M, Danova M, Rigolin GM, et al: Dendritic cells and vascular endothelial growth factor in colorectal cancer: correlations with clinicobiological findings. Oncology. 2005, 68: 276-84. 10.1159\/000086784.","journal-title":"Oncology"},{"key":"325_CR42","doi-asserted-by":"publisher","first-page":"941","DOI":"10.1038\/nri1498","volume":"4","author":"D Gabrilovich","year":"2004","unstructured":"Gabrilovich D: Mechanisms and functional significance of tumour-induced dendritic-cell defects. Nature reviews. 2004, 4: 941-52. 10.1038\/nri1498.","journal-title":"Nature reviews"},{"key":"325_CR43","doi-asserted-by":"publisher","first-page":"661","DOI":"10.1016\/j.imbio.2005.07.004","volume":"210","author":"JP Tsai","year":"2005","unstructured":"Tsai JP, Chen HW, Cheng ML, et al: Analysis of host versus tumor interaction in cancer patients: opposing role of transforming growth factor-beta1 and interleukin-6 in the development of in situ tumor immunity. Immunobiology. 2005, 210: 661-71. 10.1016\/j.imbio.2005.07.004.","journal-title":"Immunobiology"},{"key":"325_CR44","doi-asserted-by":"publisher","first-page":"3448","DOI":"10.4049\/jimmunol.177.5.3448","volume":"177","author":"G Bellone","year":"2006","unstructured":"Bellone G, Carbone A, Smirne C, et al: Cooperative induction of a tolerogenic dendritic cell phenotype by cytokines secreted by pancreatic carcinoma cells. J Immunol. 2006, 177: 3448-60.","journal-title":"J Immunol"},{"key":"325_CR45","first-page":"483","volume":"3","author":"DI Gabrilovich","year":"1997","unstructured":"Gabrilovich DI, Corak J, Ciernik IF, Kavanaugh D, Carbone DP: Decreased antigen presentation by dendritic cells in patients with breast cancer. Clin Cancer Res. 1997, 3: 483-90.","journal-title":"Clin Cancer Res"}],"container-title":["Journal of Experimental &amp; Clinical Cancer Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/1756-9966-29-78.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,9,1]],"date-time":"2021-09-01T11:52:46Z","timestamp":1630497166000},"score":1,"resource":{"primary":{"URL":"https:\/\/jeccr.biomedcentral.com\/articles\/10.1186\/1756-9966-29-78"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2010,6,18]]},"references-count":45,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2010,12]]}},"alternative-id":["325"],"URL":"https:\/\/doi.org\/10.1186\/1756-9966-29-78","relation":{},"ISSN":["1756-9966"],"issn-type":[{"value":"1756-9966","type":"electronic"}],"subject":[],"published":{"date-parts":[[2010,6,18]]},"assertion":[{"value":"29 March 2010","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"18 June 2010","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"18 June 2010","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}}],"article-number":"78"}}